News
Watch latest news
-
April 22nd, 2020Bienvenida a la Federación ASEM!
The European... -
April 22nd, 2020Welcome, CMT China!
The... -
April 22nd, 2020Welcome, CMT Israel!
We are... -
March 27th, 2020Promising news for CMT1As
Pharma company... -
March 19th, 2020Pharnext’s treatment for Charcot Marie Tooth 1A
It... -
March 11th, 2020Results from the Phase 2 Acceleron Trial of ACE-083
Acceleron... -
February 28th, 2020Rare Disease Day
Rare Disease... -
January 10th, 2020Get involved in the EURORDIS Rare Barometer Programme!
The new R-Barometer H-CARE survey on the care experience of patients with... -
January 7th, 2020Good news for CMT 1A and 1B
InFlectis BioScience Announces Successful Completion of Phase 1 Clinical Trial of... -
January 7th, 2020Charcot Marie Tooth 1A
Pharnext Announces Encouraging Data from Open-Label Phase 3 Extension Study of PXT3003... -
December 11th, 2019TREAT-NMD Alliance
We are... -
December 9th, 2019Herzlich willkommen bei CMT NET
The European...